MENT
Protein MENT
Also known as: C1orf56, FLJ20519, MENT_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BUN1
- Gene
- MENT
- Ensembl
- ENSG00000143443
- Chromosome
- 1
- Canonical length
- 341 aa
- Protein class
- Predicted secreted proteins
- Secretome location
- Secreted to blood
OverviewNCBI Gene
This gene is a proto-oncogene whose promoter is methylated by DNA methyltransferase 3B (DNMT3B), which represses the proto-oncogene. However, a catalytically inactive isoform of DNMT3B is overexpressed in lymphomas, leading to hypomethylation of the proto-oncogene's promoter and derepression of the proto-oncogene. [provided by RefSeq, Sep 2016]
Canonical amino-acid sequenceUniProt
341 residues, UniProt reviewed canonical sequence.
>Q9BUN1|MENT
1 MVPAAGALLW VLLLNLGPRA AGAQGLTQTP TEMQRVSLRF GGPMTRSYRS TARTGLPRKT
61 RIILEDENDA MADADRLAGP AAAELLAATV STGFSRSSAI NEEDGSSEEG VVINAGKDST
121 SRELPSATPN TAGSSSTRFI ANSQEPEIRL TSSLPRSPGR STEDLPGSQA TLSQWSTPGS
181 TPSRWPSPSP TAMPSPEDLR LVLMPWGPWH CHCKSGTMSR SRSGKLHGLS GRLRVGALSQ
241 LRTEHKPCTY QQCPCNRLRE ECPLDTSLCT DTNCASQSTT STRTTTTPFP TIHLRSSPSL
301 PPASPCPALA FWKRVRIGLE DIWNSLSSVF TEMQPIDRNQ RLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MENT can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.61
- Highest tissue expression
- 72 nTPM
Expression across tissuesHPA
Tissue
- testis: 72 nTPM
- adrenal gland: 9.8 nTPM
- pituitary gland: 9.5 nTPM
- liver: 8 nTPM
- thyroid gland: 7.9 nTPM
- heart muscle: 7.5 nTPM
Single-cell type
- late primary spermatocytes: 751 nCPM
- early spermatids: 412 nCPM
- esophageal apical cells: 149 nCPM
- nk-cells: 133 nCPM
- microglia: 119 nCPM
- epicardial cells: 118 nCPM
Immune cell
- basophil: 225 nTPM
- naive CD8 T-cell: 91 nTPM
- gdT-cell: 91 nTPM
- memory CD8 T-cell: 81 nTPM
- memory CD4 T-cell: 79 nTPM
- MAIT T-cell: 70 nTPM
Brain region
- cerebellum: 8.7 nTPM
- choroid plexus: 8.4 nTPM
- white matter: 8.3 nTPM
- medulla oblongata: 8 nTPM
- spinal cord: 7.9 nTPM
- basal ganglia: 7.7 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.61
- gnomAD pLI
- 0
- DepMap mean gene effect
- -0.26
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 10% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Methylated in normal thymocytes protein
- Protein missing in infertile sperm 1, putative
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MENT as an antibody target. Whether an autoantibody or antibody against MENT could matter depends on whether native MENT is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MENT is annotated as secreted, so native MENT circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label MENT as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...